Johnson & Johnson's Options Frenzy: What You Need to Know - Johnson & Johnson ( NYSE:JNJ )
Investors with a lot of money to spend have taken a bearish stance on Johnson & Johnson ( NYSE:JNJ ) . We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't ...
Should You Buy Kenvue Stock After Its 30% Plunge?
There hasn't been much good news lately for this Johnson & Johnson spinoff.
Cullen Trims KVUE Stake With $149.5M Share Sale
Cullen Capital Management, LLC disclosed the sale of 6,565,339 shares of Kenvue ( NYSE:KVUE ) for the period ended Q2 2025. The transaction was valued at an estimated $149.46 million.Cullen Capital Management, LLC reported in a September 30, 2025SEC filingthat it reduced its position in Kenvue by ...
Why Johnson & Johnson Could Be the Ultimate Dividend King
Johnson & Johnson has increased its dividend every year for 63 consecutive years. It doesn't want to stop.
White House Highlights A Controversial 2017 Tylenol Tweet On Its Usage During Pregnancy: 'We Actually Don't Recommend…' - Kenvue ( NYSE:KVUE )
A 2017 post by Tylenol on X ( formerly Twitter ) highlighted by White House has fueled a buzz around President Donald Trump's claim that the drug is linked with autism in kids.
Spotlight on Johnson & Johnson: Analyzing the Surge in Options Activity - Johnson & Johnson ( NYSE:JNJ )
Financial giants have made a conspicuous bullish move on Johnson & Johnson. Our analysis of options history for Johnson & Johnson ( NYSE: JNJ ) revealed 17 unusual trades. Delving into the details, we found 58% of traders were bullish, while 23% showed bearish tendencies.
Kenvue Surges Over 2% Pre-Market Despite Trump Administration's Autism Warning - Kenvue ( NYSE:KVUE )
Kenvue Inc. KVUE saw its stock rise by 2.61% to $17.69 in pre-market trading on Wednesday, despite concerns stirred by President Trump's controversial comments about acetaminophen potentially being linked to autism. Check out the current price of KVUE stock here.
What's Going On With Kenvue Stock Tuesday? - Kenvue ( NYSE:KVUE )
Kenvue Inc. KVUE shares are trading higher Tuesday despite President Donald Trump saying the Food and Drug Administration will notify physicians that use of acetaminophen or Tylenol during pregnancy could be associated with increase risk of autism.
Stock Market Today: Nasdaq Futures Rise, S&P 500 Slips Amid Mixed Trade-Kenvue, Micron Tech, Nvidia In Focus - SPDR S&P 500 ( ARCA:SPY )
U.S. stock futures were fluctuating on Tuesday following Monday's record advances. Futures of major benchmark indices were mixed. Fueled by expectations that the AI trade and future Federal Reserve interest-rate cuts will continue to power the market, stocks surged on Monday to secure a third ...
Jim Cramer Says Trump Is Creating 'A Nightmare' For Kenvue As President Links Tylenol With Autism - Kenvue ( NYSE:KVUE )
CNBC's Jim Cramer warned Tuesday that President Donald Trump is creating a "nightmare of potential litigation" for consumer health giant Kenvue Inc. KVUE, sending the company's stock tumbling.
Trump admin draws unproven link between autism and Tylenol ingredient use during pregnancy
Officials warned pregnant women against using acetaminophen unless they have a fever, and touted a lesser-known drug as a potential treatment for autism.
Kenvue Stock Is Sliding Today: What's Fueling The Sell-Off? - Kenvue ( NYSE:KVUE )
Shares of Kenvue Inc KVUE are down Monday in anticipation of a negative Trump administration announcement about one of its products. What To Know: Kevnue produces pain medication Tylenol, which acetaminophen is an active ingredient in.
Trump Administration To Unveil Tylenol-Autism Review, Tout This Drug As Potential Treatment: Report - Kenvue ( NYSE:KVUE ) , Pfizer ( NYSE:PFE )
The Trump administration is expected to unveil new efforts on Monday examining whether one widely used drug may be linked to autism and whether another could help treat it, according to people familiar with the plans who spoke to The Washington Post on condition of anonymity because the ...
Trump administration reportedly plans to link autism to Tylenol use during pregnancy
Federal health officials also are expected to highlight leucovorin as a potential autism treatment, according to The Washington Post.
Jim Cramer's Warning On This Oil Stock: 'You Don't Want To Be In It' - Johnson Controls Intl ( NYSE:JCI ) , International Money ( NASDAQ:IMXI )
On CNBC's "Mad Money Lightning Round," Jim Cramer said The Western Union Company WU has got no growth. Western Union, on Aug. 10. announced the acquisition of Intermex IMXI for approximately $500 million. The acquisition is set to bolster Western Union's position in the high-growth Latin American ...
Top Wide-Moat Stocks Worth a Look for Sustainable Growth
MSFT, JNJ, NKE and SPGI use strong moats to fend off rivals and deliver consistent returns amid market shifts.
What the Options Market Tells Us About Johnson & Johnson - Johnson & Johnson ( NYSE:JNJ )
High-rolling investors have positioned themselves bearish on Johnson & Johnson JNJ, and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's tracking of publicly available options data.
Kenvue Pushes To Defend Pain Killer Tylenol Against Autism Claims Ahead Of Government Report - Kenvue ( NYSE:KVUE )
A 2024 JAMA study of 2.5 million births found no increased autism risk linked to acetaminophen use during pregnancy. Executives presented scientific data and expert opinions asserting that no clear causal connection between acetaminophen and autism.
Persephone Biosciences Unveils First-Of-Its-Kind Synbiotic Designed To Restore Critical Gut Microbes In Babies
Newly released data shows that nine in ten babies lack critical gut microbes needed for healthy development. Persephone's Daily Synergistic Synbiotic, built on the largest and most comprehensive U.S. infant gut microbiome study, can help restore them.
RFK Jr. To Link Tylenol Use To Autism: Report - Kenvue ( NYSE:KVUE )
RFK Jr. is preparing to release a report suggesting that the use of Tylenol during pregnancy may be tied to a higher risk of autism. September's volatility catalysts are coming. Find out how to trade new inflation reports and fed signals here → Health Secretary Robert F.
Kenvue stock drops 10% on report RFK Jr. will link autism to Tylenol use during pregnancy
HHS will release the report that could draw that link between the pain medication and autism this month, according to the Wall Street Journal.
3 Mid-Cap Value Mutual Funds to Buy Amid Volatile Market Conditions
Amid market volatility, TGVOX, VASVX and TRMCX stand out with strong returns, low costs and exposure to growth-driven mid-cap value stocks.
J&J Stock Trading Above 200 & 50 Day SMA for 2 Months: Time to Buy?
Johnson & Johnson stock surges above key moving averages as strong results, raised guidance and growth prospects fuel momentum.
3 Stable Dividend-Paying Stocks That Are Perfect for Retirees
Names you've heard of with track records to love.
Sender Buys Into the Turnaround Story at Kenvue
According to an SEC filing published August 15, 2025, Sender Co & Partners, Inc. increased its position in Kenvue ( NYSE:KVUE ) by 530,717 shares. The estimated trade value, based on the period's average share price, was approximately $12.08 million.
Johnson & Johnson EVP Sells JNJ Shares Worth $3 Million
John C. Reed, Executive Vice President, Innovative Medicine and R&D of Johnson & Johnson ( NYSE:JNJ ) , executed an open market sale of 19,137 shares as disclosed in a Form 4 filed July 18, 2025.How does this transaction compare to John C.
Got $1,000? 3 Dividend Stocks to Buy and Hold Forever
Dip into a beaten-down market sector for deals on some proven winners.
Kenvue ( KVUE ) Q2 Sales Drop 4%
Kenvue ( NYSE:KVUE ) , the consumer health company best known for brands like Tylenol and Band-Aid, reported its earnings for the second quarter on August 7, 2025. The main news from the release: Non-GAAP earnings per share reached $0.29, narrowly beating analyst forecasts of $0.28 ( non-GAAP ) , ...
Kenvue ( KVUE ) Q2 Earnings Top Estimates
Kenvue (KVUE) delivered earnings and revenue surprises of +3.57% and -0.51%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Edgewell Personal Care ( EPC ) Misses Q3 Earnings and Revenue Estimates
Edgewell Personal (EPC) delivered earnings and revenue surprises of -8.91% and -4.54%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Countdown to Kenvue ( KVUE ) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
Besides Wall Street's top-and-bottom-line estimates for Kenvue (KVUE), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.
Analysts Estimate Kenvue ( KVUE ) to Report a Decline in Earnings: What to Look Out for
Kenvue (KVUE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should J&J Stock Be in Your Portfolio After Q2 Beat & Guidance Raise?
JNJ jumps over 6% on Q2 earnings beat and full-year guidance increase, driven by strong pharma sales and improved MedTech sales.
Deal Dispatch: Del Taco Tanks, Tylenol Maker Aches, Joyebells Cooked - Clearside Biomedical ( NASDAQ:CLSD ) , Bausch & Lomb ( NYSE:BLCO )
Tylenol and Listerine maker Kenvue Inc. KVUE just named board member Kirk Perry as interim CEO, replacing Thibaut Mongon, as part of a strategic review to boost shareholder value.
4 Mid-Cap Value Mutual Funds for Long-Term Gains
VASVX, TAMVX, TRVPX and FVLKX offer mid-cap value exposure with solid returns, low fees, and long-term growth potential.
Is Johnson & Johnson a Good Dividend Stock to Buy Now?
For decades, Johnson & Johnson ( NYSE: JNJ ) stock was favored by investors seeking steady gains. Looking at its post-COVID-19 performance, though, steady gains aren't what investors received.When the market closed on Tuesday, July 15, shares of Johnson & Johnson or J&J, were down 7.5% in the ...
JNJ Begins Drug Sector Q2 Earnings With a Beat & Guidance Raise
JNJ tops second-quarter estimates and raises 2025 guidance as Innovative Medicines outperforms and MedTech gains momentum.
3 Magnificent S&P 500 Dividend Stocks Down 16% to 20% to Buy and Hold Forever
If you look at the history of the S&P 500 ( SNPINDEX: ^GSPC ) index, dividend stocks have played a significant role in shareholder returns. Over the past 25 years, for example, while the S&P 500 rose over 300%, the power of dividend reinvestment and compounding pushed its total returns to over ...
Company News for Jul 15, 2025
Companies in The News Are: ...
Want to Generate at Least $1,000 in Passive Income Per Year? Invest $26,000 in This Dividend King Stock.
The stock market has historically been a highly effective tool for compounding wealth over time. Another way to use the stock market to achieve your financial goals is to generate income from dividend stocks.Sometimes, it can make sense to target a stodgy company with a high yield, rather than ...
Should J&J Stock Be in Your Portfolio Ahead of Q2 Earnings?
JNJ eyes Q2 growth with strong drug sales and new launches, but Stelara biosimilars and MedTech headwinds loom.
What Is Considered a Good Dividend Stock? 3 Healthcare Stocks That Fit the Bill
A steady dose of quality companies will keep your portfolio growing big and strong.
Looking to Generate Passive Income? Consider These 3 Rock-Solid Dividend King Stocks
Investing in the stock market over a long-term time horizon can be an excellent way to compound your savings. However, the path toward unlocking significant gains can be marked by numerous ups and downs.Risk-averse investors or those nearing retirement may prefer dividend stocks over growth ...
Pioneering New Study Finds Most U.S. Babies Lack Key Gut Bacteria, Increasing Risk for Allergies and Other Chronic Health Issues
Initial findings published today in Communications Biology - a Nature portfolio journal - show that 76% of infants in the U.S. are deficient in Bifidobacterium, a gut microbiome genus responsible for the utilization of human milk oligosaccharides ( HMOs )
J&J Adds More Than $15B in Six Months: How to Play JNJ Stock?
JNJ stock added $15B in market value in six months as new drug launches offset MedTech and Stelara headwinds.
Johnson & Johnson Unusual Options Activity For June 20 - Johnson & Johnson ( NYSE:JNJ )
Whales with a lot of money to spend have taken a noticeably bearish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson JNJ we detected 9 trades. If we consider the specifics of each trade, it is accurate to state that 33% of the investors opened trades with bullish ...
How Is The Market Feeling About Kenvue? - Kenvue ( NYSE:KVUE )
Kenvue's KVUE short percent of float has fallen 34.12% since its last report. The company recently reported that it has 32.46 million shares sold short, which is 2.24% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.91 days to cover their ...
2 Dividend Stocks to Buy and Never Sell
There are excellent reasons to invest in dividend stocks, including the fact that they typically outperform their non-dividend-paying peers in delivering strong market returns over long periods.However, just because a company pays a dividend doesn't make it attractive in and of itself.
A Look Into Kenvue Inc's Price Over Earnings - Kenvue ( NYSE:KVUE )
Looking into the current session, Kenvue Inc. KVUE shares are trading at $21.43, after a 1.36% decrease. Over the past month, the stock decreased by 8.61%, but over the past year, it actually increased by 16.05%.
Asia Markets Rise, Europe Follows; Dollar Pressured As Trade Talks In Focus - Global Markets Today While US Slept - SmartETFs Asia Pacific Dividend Builder ETF ( ARCA:ADIV )
Crude Oil WTI traded higher by 0.33% at $63.62/bbl, and Brent was up 0.35% at $65.68/bbl. Gold traded higher by 0.24% to $3,385.27, Silver rose 0.12% to $34.675, and Copper was up 0.88% to $4.8765. Rebound or breakdown? See how Matt Maley is trading June's market volatility, live this Wednesday, ...
